Last reviewed · How we verify
NCT05414812
Intervening on Women's Health for Rural Young Breast Cancer Survivors
NA trial testing Multi-component oncofertility care intervention in Breast Cancer in 81 participants. Completed in 30 April 2024.
30 April 2024
Quick facts
| Lead sponsor | University of California, San Diego |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 81 |
| Start date | 15 October 2021 |
| Primary completion | 30 April 2024 |
| Estimated completion | 30 April 2024 |
| Sites | 4 locations across United States |
Drugs / interventions tested
- Multi-component oncofertility care intervention
Conditions studied
- Breast Cancer — all drugs for Breast Cancer →
- Fertility — all drugs for Fertility →
- Contraception — all drugs for Contraception →
- Menopausal Symptoms — all drugs for Menopausal Symptoms →
Sponsor
University of California, San Diego
Who can join
Adults 18 to 50, female only, with Breast Cancer or Fertility. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate the effectiveness of a multi-component intervention to improve young breast cancer survivors' engagement in goal-concordant oncofertility care, concurrently with observing and gathering information on how the intervention is implemented. The investigators hypothesize that implementation of the intervention will result in increased young breast cancer survivors' engagement in goal-concordant oncofertility care.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Intervening on women's health for rural young breast cancer survivors: A study protocol.
Romero SAD, Palomino H, Ahmed SH, Peacher D, et al · · 2023 · cited 4× · PMID 37164298 · DOI 10.1016/j.cct.2023.107215
Verify or expand the search:
- PubMed search for NCT05414812
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Multi-component oncofertility care intervention
Trials testing the same drug.
- NCT05443737 — Evaluation of a Telehealth Oncofertility Care Intervention in Adolescent and Young Adult Cancer Patients · Phase 3 · recruiting
Other recruiting trials for Breast Cancer
Currently open trials in the same condition.
- NCT06148038 — CBD for Breast Cancer Primary Tumors · Phase 1 · recruiting
- NCT07405801 — A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus R · Phase 2 · recruiting
- NCT07285993 — Detection and Outcomes in Metastatic Invasive Lobular Breast Cancer Through Novel F-18 FAP PET · Phase 2 · recruiting
- NCT07510698 — Same-Day Awake Mastectomy With Immediate Breast Reconstruction for Patients With Breast Cancer · NA · recruiting
- NCT06768931 — Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer · Phase 2 · recruiting
Other University of California, San Diego trials
Trials by the same sponsor.
- NCT07342543 — Guided Physical Activity Counseling for Hypertension in Primary Care · NA · not yet recruiting
- NCT06505317 — Artificial Intelligence for Early Detection of Peripheral Artery Disease · NA · not yet recruiting
- NCT07211802 — CKM For Safe Use of SGLT2i in Type 1 Diabetes · Phase 3 · not yet recruiting
- NCT07524751 — Culturally Adapted Pain Management for Indigenous Peoples · NA · not yet recruiting
- NCT07518784 — Accurate Point of Care Liver Disease Diagnostics (Phase 2) · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05414812 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of California, San Diego
- Last refreshed: 10 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05414812.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing